<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d287">
    <sentence id="DDI-DrugBank.d287.s0" text="Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances.">
        <entity charOffset="0-9" id="DDI-DrugBank.d287.s0.e0" text="Cevimeline" type="drug"/>
        <entity charOffset="66-92" id="DDI-DrugBank.d287.s0.e1" text="beta adrenergic antagonists" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d287.s0.e0" e2="DDI-DrugBank.d287.s0.e1" id="DDI-DrugBank.d287.s0.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d287.s1" text="Drugs with parasympathomimetic effects administered concurrently with cevimeline can be expected to have additive effects.">
        <entity charOffset="70-79" id="DDI-DrugBank.d287.s1.e0" text="cevimeline" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d287.s2" text="Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly.">
        <entity charOffset="0-9" id="DDI-DrugBank.d287.s2.e0" text="Cevimeline" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d287.s3" text="Drugs which inhibit CYP2D6 and CYP3A3/4 also inhibit the metabolism of cevimeline.">
        <entity charOffset="71-80" id="DDI-DrugBank.d287.s3.e0" text="cevimeline" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d287.s4" text="Cevimeline should be used with caution in individuals known or suspected to be deficient in CYP2D6 activity, based on previous experience, as they may be at a higher risk of adverse events.">
        <entity charOffset="0-9" id="DDI-DrugBank.d287.s4.e0" text="Cevimeline" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d287.s5" text="In an in vitro study, cytochrome P450 isozymes 1A2, 2A6, 2C9, 2C19, 2D6, 2E1, and 3A4 were not inhibited by exposure to cevimeline.">
        <entity charOffset="120-129" id="DDI-DrugBank.d287.s5.e0" text="cevimeline" type="drug"/>
    <negationtags>In an in vitro study, cytochrome P450 isozymes 1A2, 2A6, 2C9, 2C19, 2D6, 2E1, and 3A4 were &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; inhibited by exposure to cevimeline. &lt;/scope&gt;</negationtags></sentence>
</document>